Laccourreye O, Gutierrez-Fonseca R, Garcia D, Hans S, Hacquart N, Ménard M, Brasnu D
Department of Otorhinolaryngology-Head and Neck Surgery, Laënnec Hospital, Assistance Publique Hôpitaux de Paris, University of Paris V, France.
Cancer. 1999 Jun 15;85(12):2549-56.
BACKGROUND: Based on an inception cohort of 103 patients who had local recurrence (Group I) and a witness group of 311 patients who achieved local control (Group II) after vertical partial laryngectomy for Stage I-II glottic carcinoma, the current retrospective study documented the consequences and management of local recurrence. METHODS: Three hundred two patients (97.1%) in Group II and all 103 patients (100%) in Group I were followed until death or for a minimum of 10 years. Statistical analysis of survival, lymph node control, and distant metastasis was based on the Kaplan-Meier product limit method. RESULTS: The 10-year actuarial survival estimate was 30.8% for Group I patients and 63.1% for Group II patients. Survival was statistically more likely to be reduced in Group I patients (P < 0.0001) than in Group II patients. The percentage of patients who died of their initial disease was 44.6% in Group I and 6.3% in Group II. The 10-year actuarial lymph node control estimate was 70.2% for Group I and 96.1% for Group II. Lymph node recurrence was statistically more likely to occur in Group I patients than in Group II patients (P < 0.0001). The 10-year actuarial estimate for patients without distant metastasis was 80.2% for Group I and 96.7% for Group II. Distant metastasis was statistically more likely to occur in Group I patients than in Group II patients (P < 0.0001). Salvage treatment was unsuitable for 4.7% of patients with local recurrence; for other patients, it yielded a 86.7% local control rate, a 21.4% laryngeal preservation rate, a 4.5% death rate, and an 11.2% rate of incidence of severe complications. CONCLUSIONS: Among patients with Stage I-II glottic carcinoma managed with vertical partial laryngectomy, local recurrence results in a reduced rate of survival as well as a high rate of necessity for salvage total laryngectomy.
背景:基于103例局部复发患者(第一组)的初始队列以及311例在I-II期声门癌垂直部分喉切除术后实现局部控制的对照患者(第二组),本项回顾性研究记录了局部复发的后果及处理情况。 方法:第二组中的302例患者(97.1%)以及第一组中的所有103例患者(100%)均随访至死亡或至少随访10年。生存、淋巴结控制及远处转移的统计分析基于Kaplan-Meier乘积限法。 结果:第一组患者的10年精算生存率估计值为30.8%,第二组患者为63.1%。第一组患者的生存率在统计学上比第二组患者更有可能降低(P<0.0001)。死于原发疾病的患者比例在第一组为44.6%,在第二组为6.3%。第一组患者的10年精算淋巴结控制估计值为70.2%,第二组为96.1%。第一组患者发生淋巴结复发在统计学上比第二组患者更有可能(P<0.0001)。第一组无远处转移患者的10年精算估计值为80.2%,第二组为96.7%。第一组患者发生远处转移在统计学上比第二组患者更有可能(P<0.0001)。挽救性治疗不适用于4.7%的局部复发患者;对于其他患者,其局部控制率为86.7%,喉保留率为21.4%,死亡率为4.5%,严重并发症发生率为11.2%。 结论:在接受垂直部分喉切除术治疗的I-II期声门癌患者中,局部复发导致生存率降低以及挽救性全喉切除术的必要性增加。
Laryngoscope. 2004-8
Arch Otolaryngol Head Neck Surg. 2006-1
Laryngoscope. 2006-1
Arch Otolaryngol Head Neck Surg. 2004-9
Laryngoscope. 2002-7
Otolaryngol Head Neck Surg. 2003-2
Neoplasma. 2005
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2012